RxDoctor Payments Data

Joshua Light, MD

Otology & Neurotology · Boynton Beach, FLNPI 1104880921

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (57.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Intersect ENT, Inc. accounts for 78.6% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $9,644 and has fallen 96.8% since, to $304 in 2025.

$12,283in general payments, 2019–2025

Across 85 payments — averaging $144.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$10K
  • Aerin Medical Inc.$759
  • Regeneron Healthcare Solutions, Inc.$409
  • Acclarent, Inc$314
  • Medtronic$309
  • Sanofi$120
  • plus $720 from 16 others
$77,953in research payments, 2019–2025

Across 42 payments — averaging $1856.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intersect ENT, Inc.$20K
  • Neurent Medical Limited$18K
  • Stryker$18K
  • Medtronic$11K
  • Arrinex, Inc.$6K
  • Otonomy, Inc.$5K

What the payments were for

  • Consulting fees$2,00016%
  • Speaking & faculty fees$7,00057%
  • Travel & lodging$3032%
  • Food & beverage$2,98024%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,283 in reported general payments places this provider in the 70th percentile of 25 otology & neurotology providers in Florida.

See all otology & neurotology providers in Florida

Medicare billing

Part B allowed, 2024
$422,367
Medicare patients
878
Services billed
6,929

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide132$4,003
Fluticasone Propionate274$3,847
Tobramycin-DexamethasoneTobramycin/Dexamethasone47$3,371
Mometasone Furoate40$857
Omeprazole59$725
Methylprednisolone72$424
Montelukast Sodium46$377
Doxycycline Monohydrate30$357
Levocetirizine Dihydrochloride30$259
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$246
Azelastine Hcl21$229
Levofloxacin30$187
Mupirocin23$156
Paroxetine Hcl14$106
Prednisone27$72

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Boynton Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →